טוען...
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
BACKGROUND: It has been proposed that peroxisome proliferator-activated receptor-γ (PPARγ) agonists might reduce renal fibrosis, however, several studies had contradictory results. Moreover, the possible interaction of TGF-β(1), PPARγ, and transcription factors in renal fibrosis have not been invest...
שמור ב:
| הוצא לאור ב: | BMC Nephrol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6610924/ https://ncbi.nlm.nih.gov/pubmed/31277592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1431-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|